← All trials
NCT07095205
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 3, 2024
- Primary completion
- Sep 30, 2029
- Completion date
- Sep 30, 2029
- First posted
- Jul 31, 2025
- Last posted
- Jul 31, 2025
- Enrollment
- 14
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Stony Brook UniversityLead sponsor
- Stony Brook UniversityOfficial
- National Institute of Mental Health (NIMH)Collaborator
- National Institutes of Health (NIH)Collaborator
- Stony Brook UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.